Notable Bullish Options Activity in Merck (MRK) -Susquehanna

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. RXO

Go back to Notable Bullish Options Activity in Merck (MRK) -Susquehanna

Merck (MRK) Announces New, Updated Data for its KEYTRUDA and Updated Data on LYNPARZA in Multiple Breast Cancer Subtypes to Be Presented at SABCS

November 30, 2017 7:08 AM EST

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that new and updated data from six abstracts investigating KEYTRUDA® (pembrolizumab), the companys anti-PD-1 therapy, as both monotherapy and combination therapy, across a range of difficult-to-treat breast cancers, will be presented at the 2017 San Antonio Breast Cancer Symposium (SABCS), Dec. 5 9. In addition to the presentation of KEYTRUDA data at SABCS, updated data on LYNPARZA® (olaparib), the first-in-class poly ADP-ribose polymerase (PARP) inhibitor being co-developed and co-commercialized with AstraZeneca, will be presented.

KEYTRUDA presentations include a Spotlight Session with... More